RECRUITING

MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

MyPEEPS Mobile Plus, a multi-level intervention for improving HIV prevention outcomes in YMSM, is a novel and evidence-driven approach using mobile technology to deliver HIV prevention information specifically developed for YMSM. Building on strong preliminary work, the proposed research is the next logical step in a body of work designed to assess whether refinement of this mobile intervention used in combination with virtual PrEP Peer Navigation will result in improvements in PrEP uptake and a reduction in HIV-related behavior. This is key to advancing HIV prevention among HIV-negative US persons at extremely high-risk for HIV seroconversion.

Official Title

MyPEEPS Mobile Plus

Quick Facts

Study Start:2025-03-31
Study Completion:2029-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06741618

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:17 Years to 25 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * 17-25 years of age
  2. * identify as male, non-binary, or genderqueer
  3. * male sex assigned at birth
  4. * understand and read english
  5. * own a smartphone
  6. * report condomless anal sex with a male in the past year
  7. * HIV-negative (OraQuick verified)
  1. * HIV Positive
  2. * If study staff determine participant unable to consent due to obvious and severe cognitive impairment or under the influence of drugs or alcohol
  3. * Transgender identity
  4. * currently report consistent use of PrEP

Contacts and Locations

Study Contact

Rebecca Schnall, PhD, MPH
CONTACT
212-342-6886
rb897@columbia.edu

Principal Investigator

Robert Garofalo, MD, MPH
PRINCIPAL_INVESTIGATOR
Ann & Robert H Lurie Children's Hospital of Chicago
Lisa Kuhns, PhD, MPH
PRINCIPAL_INVESTIGATOR
Ann & Robert H Lurie Children's Hospital of Chicago

Study Locations (Sites)

Columbia University
New York, New York, 10032
United States

Collaborators and Investigators

Sponsor: Columbia University

  • Robert Garofalo, MD, MPH, PRINCIPAL_INVESTIGATOR, Ann & Robert H Lurie Children's Hospital of Chicago
  • Lisa Kuhns, PhD, MPH, PRINCIPAL_INVESTIGATOR, Ann & Robert H Lurie Children's Hospital of Chicago

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-31
Study Completion Date2029-12-31

Study Record Updates

Study Start Date2025-03-31
Study Completion Date2029-12-31

Terms related to this study

Keywords Provided by Researchers

  • PrEP
  • care navigation

Additional Relevant MeSH Terms

  • HIV/AIDS